Concord Healthcare Group Co. Ltd. has successfully completed the placement of 18,600,000 new H shares under a general mandate. The placement, executed by the Placing Agent, was conducted at a price of HK$5.38 per share, representing approximately 7.54% of the issued H Shares. The Board of Concord Healthcare Group announced that all conditions outlined in the Placing Agreement have been fulfilled, ensuring the placement's completion. The newly issued shares were distributed among no fewer than six investors, in line with the agreed terms and conditions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.